Long
✴️ Polygon Super Healthy, Potential To Move Above $2.35
MATICUSDT (Polygon) continues with one of the healthiest chart.
We had a 3 weeks correction that bounced off EMA100 and closed above EMA10.
Weekly, prices remain safely trading above all these moving averages (EMA10/21/50/100), this is ultra-bullish.
Higher highs and higher lows since June 2022, more to come, stay tuned.
The target is set above $2.35 but we go step by step.
Remember to boost, comment and follow.
Namaste.
We had a 3 weeks correction that bounced off EMA100 and closed above EMA10.
Weekly, prices remain safely trading above all these moving averages (EMA10/21/50/100), this is ultra-bullish.
Higher highs and higher lows since June 2022, more to come, stay tuned.
The target is set above $2.35 but we go step by step.
Remember to boost, comment and follow.
Namaste.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.